Brief

Purdue Pharma Approved For $17.5M In Ch. 11 Bonus Plans

By Vince Sullivan · September 4, 2025, 1:09 PM EDT

Bankrupt pharmaceutical company Purdue Pharma LP received approval from a New York judge Thursday to pay more than $17.5 million in employee bonuses, mirroring the bonus structures of the last few...

To view the full article, register now.

Bankruptcy Scorecard

Summary

Purdue Pharma filed for bankruptcy after reaching a settlement deal to end over 2,600 lawsuits that accused the maker of OxyContin of fueling a national opioid addiction crisis. In June 2024, the U.S. Supreme Court overturned Purdue's Chapter 11 plan finding non-debtor third parties, like Purdue's former owners the Sackler family, aren't authorized to receive non-consensual liability waivers under the U.S. Bankruptcy Code.

Case Number

19-bk-23649

Judge

Sean H. Lane

Venue

U.S. Bankruptcy Court for the Southern District of New York

Capital Structure

View Full Scorecard

Case Information

Case Title

Purdue Pharma L.P.

Case Number

7:19-bk-23649

Court

New York Southern

Nature of Suit

Date Filed

September 15, 2019